ABT Technical Analysis
As of date:6/28/2022
ABT stock price:106.97
ABT 50 DMA:112.48
ABT 200 DMA:121.59
ABT MACD (200-50):9.11
ABT RSI:32.55
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)32.55
Extremely
Oversold

Also see:
ABT Market Cap History
ABT Shares Outstanding History
ABT YTD Return

Try ChartSweeps today
Quotes delayed 20 minutes

Email EnvelopeFree ABT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

WEYS Crosses Below Key Moving Average Level
1 hour, 28 minutes ago


REPX Crosses Below Key Moving Average Level
1 hour, 43 minutes ago


IVT Makes Notable Cross Below Critical Moving Average
1 hour, 43 minutes ago


Enphase Energy (ENPH) Shares Cross Below 200 DMA
6 hours, 23 minutes ago


Notable Two Hundred Day Moving Average Cross - CRZBF
6 hours, 34 minutes ago


EFN.CA Crosses Below Key Moving Average Level
7 hours, 12 minutes ago


ULTA Makes Notable Cross Below Critical Moving Average
Tuesday, June 28, 4:25 PM


Landec Breaks Below 200-Day Moving Average - Notable for LNDC
Tuesday, June 28, 4:24 PM


CVG.CA Crosses Above Key Moving Average Level
Tuesday, June 28, 3:42 PM


TCOM Crosses Above Key Moving Average Level
Tuesday, June 28, 12:35 PM


Notable Two Hundred Day Moving Average Cross - SHEN
Tuesday, June 28, 12:35 PM


Republic Bancorp Breaks Above 200-Day Moving Average - Bullish for RBCAA
Tuesday, June 28, 12:32 PM


Bullish Two Hundred Day Moving Average Cross - CHMG
Tuesday, June 28, 12:31 PM


China Eastern Airlines (CEA) Shares Cross Above 200 DMA
Tuesday, June 28, 11:01 AM


National Retail Properties (NNN) Shares Cross Above 200 DMA
Tuesday, June 28, 10:59 AM


More Technical Analysis News

ABT Technical AnalysisABT RSI
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a range of health care products. Co.'s segments are: Established Pharmaceutical Products, which includes a line of generic pharmaceuticals; Diagnostic Products, which includes a line of diagnostic systems and tests; Nutritional Products, which includes a line of pediatric and adult nutritional products; Medical Devices, which includes a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain.

When researching a stock like Abbott Laboratories, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from ABT Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for ABT stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ABT DMAABT MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Abbott Laboratories (ABT) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

ALGN Technical Analysis
AMGN Technical Analysis
BAX Technical Analysis
BDX Technical Analysis
BIIB Technical Analysis
BIO Technical Analysis
BMY Technical Analysis
BSX Technical Analysis
CAH Technical Analysis
CI Technical Analysis
More Healthcare companies »

 

ABT Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2022, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.